VVector Bio was founded to contribute to filling the current gap for complex molecule drug manufacturing and support Research & Development and clinical studies of novel biological products. The company provides expert services in process development (upstream and downstream), cell line development, gene therapy viral vector design and production (Adeno-associated virus (AAV), lentivirus), virus and viral vector-based vaccines and recombinant protein production. Our manufacturing technology allows high production yields in HEK-293 suspension cells and baculovirus-insect cell systems. VVector Bio headquarter is located in Montreal, Canada within McGill University campus.
Our mission is to provide our clients with the best biomanufacturing solutions and quality products so that their biologics become a successful clinical reality.
Our vision is to become a global leader CDMO providing efficient biomanufacturing solutions for biologics at a reduced time and cost.
The directors at VVector Bio have more than 15 years of experience in manufacturing of viruses, virus-like particles, viral vectors and recombinant proteins from different cell hosts. Our staff is multidisciplinary and fully trained to provide services of excellence in the manufacturing of biologics. We commit to projects on process development and/or production of diverse biologics. Our team of experts will provide guidance, if required, through the entire project. We work closely with our clients to develop and execute the production process of their precious biological material, within the expected timelines, with high quality and professionalism. Once the project is completed, we provide our clients with a detailed report summarizing the technical work undertaken plus scientific discussion.
VVECTOR BIO, Bridging Research and Clinic
2020 VVECTOR BIO. All Rights Reserved